448 related articles for article (PubMed ID: 8917681)
1. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
Min KS; Onosaka S; Tanaka K
Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
[TBL] [Abstract][Full Text] [Related]
2. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
Vestergaard P; Shaikh ZA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
Wang XP; Chan HM; Goyer RA; Cherian MG
Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
[TBL] [Abstract][Full Text] [Related]
5. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
Liu J; Habeebu SS; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats.
Chan HM; Zhu LF; Zhong R; Grant D; Goyer RA; Cherian MG
Toxicol Appl Pharmacol; 1993 Nov; 123(1):89-96. PubMed ID: 8236266
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of hepatic cadmium in pregnant rats.
Chan HM; Cherian MG
Toxicol Appl Pharmacol; 1993 Jun; 120(2):308-14. PubMed ID: 8511801
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration.
Liu Y; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2001 Sep; 175(3):253-9. PubMed ID: 11559024
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
Tang W; Sadovic S; Shaikh ZA
Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
[TBL] [Abstract][Full Text] [Related]
12. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
Squibb KS; Pritchard JB; Fowler BA
J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
[TBL] [Abstract][Full Text] [Related]
13. Cd-metallothionein nephrotoxicity in inbred strains of mice.
Sendelbach LE; Kershaw WC; Cuppage F; Klaassen CD
J Toxicol Environ Health; 1992 Feb; 35(2):115-26. PubMed ID: 1542133
[TBL] [Abstract][Full Text] [Related]
14. Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats.
Morales AI; Vicente-Sánchez C; Jerkic M; Santiago JM; Sánchez-González PD; Pérez-Barriocanal F; López-Novoa JM
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):128-35. PubMed ID: 16226777
[TBL] [Abstract][Full Text] [Related]
15. Effects of hepatic disorder on the fate of cadmium in rats.
Tanaka K
Dev Toxicol Environ Sci; 1982; 9():237-49. PubMed ID: 7053969
[TBL] [Abstract][Full Text] [Related]
16. Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium-metallothionein.
Sendelbach LE; Klaassen CD
Toxicol Appl Pharmacol; 1988 Jan; 92(1):95-102. PubMed ID: 3341030
[TBL] [Abstract][Full Text] [Related]
17. Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure.
Liang Y; Li H; Xiang C; Lei L; Jin T; Nordberg M; Nordberg GF
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):348-55. PubMed ID: 20030629
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of intravenously injected cadmium-metallothionein: critical concentration and tolerance.
Maitani T; Cuppage FE; Klaassen CD
Fundam Appl Toxicol; 1988 Jan; 10(1):98-108. PubMed ID: 3350234
[TBL] [Abstract][Full Text] [Related]
19. Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules--A light microscopic autoradiography study with 109CdMT.
Dorian C; Gattone VH; Klaasen CD
Toxicol Appl Pharmacol; 1992 Jun; 114(2):173-81. PubMed ID: 1609408
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific cadmium accumulation, metallothionein induction, and tissue zinc and copper levels during chronic sublethal cadmium exposure in juvenile rainbow trout.
Hollis L; Hogstrand C; Wood CM
Arch Environ Contam Toxicol; 2001 Nov; 41(4):468-74. PubMed ID: 11598784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
